EVIDENCE THAT INCREASED HIPPOCAMPAL EXPRESSION OF THE CYTOKINE INTERLEUKIN-1-BETA IS A COMMON TRIGGER FOR AGE-INDUCED AND STRESS-INDUCED IMPAIRMENTS IN LONG-TERM POTENTIATION
Ca. Murray et Ma. Lynch, EVIDENCE THAT INCREASED HIPPOCAMPAL EXPRESSION OF THE CYTOKINE INTERLEUKIN-1-BETA IS A COMMON TRIGGER FOR AGE-INDUCED AND STRESS-INDUCED IMPAIRMENTS IN LONG-TERM POTENTIATION, The Journal of neuroscience, 18(8), 1998, pp. 2974-2981
Several cytokines and their receptors are identified in brain; one of
these is the proinflammatory cytokine interleukin-1 beta that is synth
esized and released from neurons and glia in response to stress or ins
ult. Among the actions of interleukin-1 beta is its ability to inhibit
long-term potentiation in the hippocampus in vitro, an action that mi
mics one of the consequences of stress and age. It has been shown that
the concentration of interleukin-1 beta in brain tissue is increased
in neurodegenerative conditions, and recent evidence from our laborato
ry has indicated an increase in the concentration of interleukin-1 bet
a in the hippocampus of aged rats. These observations led us to consid
er that the underlying common cause of impaired long-term potentiation
in aged and stressed rats might be increased endogenous interleukin-1
beta concentration in hippocampus. The data presented here indicate t
hat there was an inverse relationship between concentration of interle
ukin-1 beta in the dentate gyrus and long-term potentiation in perfora
nt path-->granule cell synapses in aged rats, stressed rats, and rats
pretreated with interleukin-1 beta. The evidence suggested that the cy
tokine induces formation of reactive oxygen species that triggers lipi
d peroxidation in vivo, as well as in vitro, and that these changes le
ad to depletion of membrane arachidonic acid that correlates with impa
ired long-term potentiation. We propose that three theories of aging,
the glucocorticoid theory, the membrane theory, and the free radical t
heory, constitute three facets of age with one underlying trigger: an
increase in the endogenous concentration of interleukin-1 beta in hipp
ocampus.